Stock 531015 VENMAX DRUGS AND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Venmax Drugs and Pharmaceuticals Limited

Equities

531015

INE154G01022

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Venmax Drugs and Pharmaceuticals Limited Approves Resignation of Sadan Grover from the Post of Company Secretary & Compliance Officer
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Announces Change in Management
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Auditor Raises 'Going Concern' Doubt
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Venmax Drugs and Pharmaceuticals Limited Approves Shifting of Registered Office
CI
Venmax Drugs and Pharmaceuticals Limited Proposes the Resignation of Shri Ramakrishnaiah Appanaboyana as Independent Director
CI
Venmax Drugs and Pharmaceuticals Limited Announces Executive Changes
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 531015 Stock
  4. News Venmax Drugs and Pharmaceuticals Limited